Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Extension Study for Patients With Spinal Muscular Atrophy Who Previously Participated in Investigational Studies of ISIS 396443

NCT02594124 is registered in ClinicalTrials.gov with Biogen as lead sponsor.

NCT NCT02594124
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02594124 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Extension Study for Patients With Spinal Muscular Atrophy Who Previously Participated in Investigational Studies of ISIS 396443
Lead sponsor
Biogen
Phase
Phase 3
Overall status
Completed
Start date
November 4, 2015
Completion date
August 21, 2023
Enrollment
292 (actual)
Sites
47

Conditions

As the registry lists them; a condition with its own page is linked.

spinal muscular atrophy